What is the Agency doing under the Toxic Substances Control Act (TSCA) relating to PBDEs?
EPA promulgated a Significant New Use Rule (SNUR) (PDF) (7 pp, 130K, About PDF) in the Federal Register to require notification to EPA ninety days prior to US manufacture or import, for any use, of the commercial products pentaBDE and octaBDE after January 1, 2005. This action is a follow-up to a voluntary phase-out of these chemicals by Great Lakes Chemical Corporation (now Chemtura Corporation), the only U.S. manufacturer of pentaBDE and octaBDE. Production in the United States of these two chemicals ceased at the end of 2004. A question and answer document on the PBDE SNUR is also available. What is the Agency doing to better understand the possible risks from PBDEs? EPA is engaged in the Voluntary Childrens Chemical Evaluation Program (VCCEP), working with chemical manufacturers to provide data to enable the public to understand the potential health risks to children associated with certain chemical exposures. Through VCCEP, industry-sponsored risk assessments for pentaBDE, octaBDE
Related Questions
- What is the relationship between the HPV Challenge Program and any subsequent rulemaking under the Toxic Substances Control Act (TSCA)?
- How does the US EPA authenticate digital signatures for Toxic Substances Control Act (TSCA) Test Submissions (TSCATS)?
- What is the Agency doing under the Toxic Substances Control Act (TSCA) relating to PBDEs?
